Planta Med 1997; 63(6): 511-517
DOI: 10.1055/s-2006-957753
Papers
Pharmacology
© Georg Thieme Verlag Stuttgart · New York

The Flavonoid Constituents of Two Polypodium Species (Calaguala) and their Effect on the Elastase Release in Human Neutrophils

Mervi Vasänge1 , Boling Liu1 , Christopher J. Welch2 , Wenche Rolfsen1 , Lars Bohlin1
  • 1Division of Pharmacognosy, Department of Pharmacy, Biomedical Centre, Uppsala University, Box 579, S-751 23 Uppsala, Sweden
  • 2Division of Organic Chemistry, Department of Pharmaceutical Chemistry, Biomedical Centre, Uppsala University, Box 574, S-751 23 Uppsala, Sweden
Further Information

Publication History

1997

1997

Publication Date:
04 January 2007 (online)

Abstract

Five flavonoid compounds were isolated from two Polypodium species (P. decumanum and P. triseriale) with the common name Calaguala. Structure elucidation was carried out using different NMR techniques and revealed the presence of one new glycoside (kaempferol 3-O-β-D-xylopyranosyl-(1-2)-β-D-arabinopyranoside) (1), two known flavonoid glycosides, rutin and kaempferol 3-O-α-D-arabinopyranoside (2, 3), the trimeric proanthocyanidin, selligueain (4), and the coumarinic acid derivative, melilotoside (5). The compounds were tested for their activity in PAF induced exocytosis in human neutrophils but none of the compounds showed PAF specific activity. Instead, they showed more general effects on the neutrophil including inhibition of the spontaneous elastase release (5) and potentiation of the release induced by PAF (1). Selligueain was found to inhibit the proteolytic enzyme, elastase in vitro.

    >